ERBB2 and hepatocellular carcinoma: Butein-sensitive HER2+ BT-474 or butein-resistant HER2+ HCC-1419 cells were injected into the 4th left mammary fat pad of nude mice, and then 10 μg/ml of butein was subcutaneously injected two times a week.